Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 13 11 2018
revised: 21 01 2019
accepted: 13 02 2019
pubmed: 26 2 2019
medline: 21 5 2021
entrez: 26 2 2019
Statut: ppublish

Résumé

Partial nephrectomy (PN) in elderly patients is underutilized with concerns regarding risk of complications and potential for poor outcomes. To evaluate quality and functional outcomes of PN in patients >75 yr using trifecta as a composite outcome of surgical quality. Multicenter retrospective analysis of 653 patients aged >75 yr who underwent PN (REnal SURGery in Elderly [RESURGE] Group). PN. Primary outcome was achievement of trifecta (negative margin, no major [Clavien ≥3] urological complications, and ≥90% estimated glomerular filtration rate [eGFR] recovery). Secondary outcomes included chronic kidney disease (CKD) stage III and CKD upstaging. Multivariable analysis (MVA) was used to assess variables for achieving trifecta and functional outcomes. Kaplan-Meier survival analysis (KMA) was used to calculate renal functional outcomes. We analyzed 653 patients (mean age 78.4 yr, median follow-up 33 mo; 382 open, 157 laparoscopic, and 114 robotic). Trifecta rate was 40.4% (n=264). Trifecta patients had less transfusion (p<0.001), lower intraoperative (5.3% vs 27%, p<0.001) and postoperative (25.4% vs 37.8%, p=0.001) complications, shorter hospital stay (p=0.045), and lower ΔeGFR (p <0.001). MVA for predictive factors for trifecta revealed decreasing RENAL nephrometry score (odds ratio [OR] 1.26, 95% confidence interval 1.07-1.51, p=0.007) as being associated with increased likelihood to achieve trifecta. Achievement of trifecta was associated with decreased risk of CKD upstaging (OR 0.47, 95% confidence interval 0.32-0.62, p<0.001). KMA showed that trifecta patients had improved 5-yr freedom from CKD stage 3 (93.5% vs 57.7%, p<0.001) and CKD upstaging (84.3% vs 8.2%, p<0.001). Limitations include retrospective design. PN in elderly patients can be performed with acceptable quality outcomes. Trifecta was associated with decreased tumor complexity and improved functional preservation. We looked at quality outcomes after partial nephrectomy in elderly patients. Acceptable quality outcomes were achieved, measured by a composite outcome called trifecta, whose achievement was associated with improved kidney functional preservation.

Sections du résumé

BACKGROUND
Partial nephrectomy (PN) in elderly patients is underutilized with concerns regarding risk of complications and potential for poor outcomes.
OBJECTIVE
To evaluate quality and functional outcomes of PN in patients >75 yr using trifecta as a composite outcome of surgical quality.
DESIGN, SETTING, AND PARTICIPANTS
Multicenter retrospective analysis of 653 patients aged >75 yr who underwent PN (REnal SURGery in Elderly [RESURGE] Group).
INTERVENTION
PN.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
Primary outcome was achievement of trifecta (negative margin, no major [Clavien ≥3] urological complications, and ≥90% estimated glomerular filtration rate [eGFR] recovery). Secondary outcomes included chronic kidney disease (CKD) stage III and CKD upstaging. Multivariable analysis (MVA) was used to assess variables for achieving trifecta and functional outcomes. Kaplan-Meier survival analysis (KMA) was used to calculate renal functional outcomes.
RESULTS AND LIMITATIONS
We analyzed 653 patients (mean age 78.4 yr, median follow-up 33 mo; 382 open, 157 laparoscopic, and 114 robotic). Trifecta rate was 40.4% (n=264). Trifecta patients had less transfusion (p<0.001), lower intraoperative (5.3% vs 27%, p<0.001) and postoperative (25.4% vs 37.8%, p=0.001) complications, shorter hospital stay (p=0.045), and lower ΔeGFR (p <0.001). MVA for predictive factors for trifecta revealed decreasing RENAL nephrometry score (odds ratio [OR] 1.26, 95% confidence interval 1.07-1.51, p=0.007) as being associated with increased likelihood to achieve trifecta. Achievement of trifecta was associated with decreased risk of CKD upstaging (OR 0.47, 95% confidence interval 0.32-0.62, p<0.001). KMA showed that trifecta patients had improved 5-yr freedom from CKD stage 3 (93.5% vs 57.7%, p<0.001) and CKD upstaging (84.3% vs 8.2%, p<0.001). Limitations include retrospective design.
CONCLUSIONS
PN in elderly patients can be performed with acceptable quality outcomes. Trifecta was associated with decreased tumor complexity and improved functional preservation.
PATIENT SUMMARY
We looked at quality outcomes after partial nephrectomy in elderly patients. Acceptable quality outcomes were achieved, measured by a composite outcome called trifecta, whose achievement was associated with improved kidney functional preservation.

Identifiants

pubmed: 30799289
pii: S2405-4569(19)30030-6
doi: 10.1016/j.euf.2019.02.010
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

982-990

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Ahmet Bindayi (A)

Department ofUrology, University of California San Diego School of Medicine, La Jolla, CA, USA.

Riccardo Autorino (R)

Department of Urology Virginia Commonwealth University, Richmond, VA, USA.

Umberto Capitanio (U)

Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Nicola Pavan (N)

Urology Clinic, University of Trieste, Trieste, Italy.

Maria Carmen Mir (MC)

Instituto Valenciano de Oncologia, Valencia, Spain.

Alessandro Antonelli (A)

Department of Urology, Spedali Civili Hospital, Brescia, Italy.

Toshio Takagi (T)

Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.

Riccardo Bertolo (R)

Department of Urology, University of Turin-San Luigi Gonzaga Hospital, Turin, Italy.

Tobias Maurer (T)

Department of Urology, Technical University of Munich, Munich, Germany.

Koon Ho Rha (K)

Urological Science Institute, Yonsei University College of Medicine, Seoul, South Korea.

Jean Alexandre Long (JA)

Department of Urology, University of Grenoble, Grenoble, France.

Bo Yang (B)

Department of Urology, Changhai Hospital, Shanghai, China.

Luigi Schips (L)

Division of Urology, ASL Abruzzo 2, Chieti, Italy.

Estevão Lima (E)

CUF Urology, University of Minho, Braga, Portugal.

Alberto Breda (A)

Department of Urology, Autonoma University of Barcelona, Barcelona, Spain.

Estefania Linares (E)

Department of Urology, Hospital Universitario La Paz, Madrid, Spain.

Antonio Celia (A)

Department of Urology, San Bassiano Hospital, Bassano del Grappa, Italy.

Cosimo De Nunzio (C)

Department of Urology, Sant'Andrea Hospital, University La Sapienza, Rome, Italy.

Ryan Dobbs (R)

Department of Urology, University of Illinois-Chicago, Chicago, IL, USA.

Sunil Patel (S)

Department ofUrology, University of California San Diego School of Medicine, La Jolla, CA, USA.

Zachary Hamilton (Z)

Department ofUrology, University of California San Diego School of Medicine, La Jolla, CA, USA.

Andrew Tracey (A)

Department of Urology Virginia Commonwealth University, Richmond, VA, USA.

Alessandro Larcher (A)

Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Carlo Trombetta (C)

Urology Clinic, University of Trieste, Trieste, Italy.

Carlotta Palumbo (C)

Department of Urology, Spedali Civili Hospital, Brescia, Italy.

Kazunari Tanabe (K)

Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.

Thomas Amiel (T)

Department of Urology, Technical University of Munich, Munich, Germany.

Ali Raheem (A)

Urological Science Institute, Yonsei University College of Medicine, Seoul, South Korea.

Gaelle Fiard (G)

Department of Urology, University of Grenoble, Grenoble, France.

Chao Zhang (C)

Department of Urology, Changhai Hospital, Shanghai, China.

Roberto Castellucci (R)

Division of Urology, ASL Abruzzo 2, Chieti, Italy.

Joan Palou (J)

Department of Urology, Autonoma University of Barcelona, Barcelona, Spain.

Stephen Ryan (S)

Department ofUrology, University of California San Diego School of Medicine, La Jolla, CA, USA.

Simone Crivellaro (S)

Department of Urology, University of Illinois-Chicago, Chicago, IL, USA.

Francesco Montorsi (F)

Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Francesco Porpiglia (F)

Department of Urology, University of Turin-San Luigi Gonzaga Hospital, Turin, Italy.

Ithaar H Derweesh (IH)

Department ofUrology, University of California San Diego School of Medicine, La Jolla, CA, USA. Electronic address: iderweesh@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH